相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。ETS transcription factors as emerging drug targets in cancer
Michael Hsing et al.
MEDICINAL RESEARCH REVIEWS (2020)
ETV5 links the FGFR3 and Hippo signalling pathways in bladder cancer
Erica di Martino et al.
SCIENTIFIC REPORTS (2019)
ALK positively regulates MYCN activity through repression of HBP1 expression
Shana Claeys et al.
ONCOGENE (2019)
Activated ALK signals through the ERK-ETV5-RET pathway to drive neuroblastoma oncogenesis
Lucille Lopez-Delisle et al.
ONCOGENE (2018)
Identification and substrate prediction of new Fragaria x ananassa aquaporins and expression in different tissues and during strawberry fruit development
Britt Merlaen et al.
HORTICULTURE RESEARCH (2018)
RAS-MAPK Pathway-Driven Tumor Progression Is Associated with Loss of CIC and Other Genomic Aberrations in Neuroblastoma
Thomas F. Eleveld et al.
CANCER RESEARCH (2018)
A mechanistic classification of clinical phenotypes in neuroblastoma
Sandra Ackermann et al.
SCIENCE (2018)
Integrated proximal proteomics reveals IRS2 as a determinant of cell survival in ALK-driven neuroblastoma
Kristina B. Emdal et al.
SCIENCE SIGNALING (2018)
Fucoxanthin, a Marine Carotenoid, Attenuates beta-Amyloid Oligomer-Induced Neurotoxicity Possibly via Regulating the PI3K/Akt and the ERK Pathways in SH-SY5Y Cells
Jiajia Lin et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2017)
MEK inhibitor trametinib does not prevent the growth of anaplastic lymphoma kinase (ALK)-addicted neuroblastomas
Ganesh Umapathy et al.
SCIENCE SIGNALING (2017)
Neuroblastoma
Jason Shohet et al.
BMJ-BRITISH MEDICAL JOURNAL (2017)
Neuroblastoma
Jason Shohet et al.
BMJ-BRITISH MEDICAL JOURNAL (2017)
MEK inhibitor trametinib does not prevent the growth of anaplastic lymphoma kinase (ALK)-addicted neuroblastomas
Ganesh Umapathy et al.
SCIENCE SIGNALING (2017)
The role of the ALK receptor in cancer biology
B. Hallberg et al.
ANNALS OF ONCOLOGY (2016)
Brain-derived neurotrophic factor promotes vesicular glutamate transporter 3 expression and neurite outgrowth of dorsal root ganglion neurons through the activation of the transcription factors Etv4 and Etv5
Dong Liu et al.
BRAIN RESEARCH BULLETIN (2016)
Upregulation of MAPK Negative Feedback Regulators and RET in Mutant ALK Neuroblastoma: Implications for Targeted Treatment
Irina Lambertz et al.
CLINICAL CANCER RESEARCH (2015)
ETS-related Transcription Factors ETV4 and ETV5 Are Involved in Proliferation and Induction of Differentiation-associated Genes in Embryonic Stem (ES) Cells
Tadayuki Akagi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Relapsed neuroblastomas show frequent RAS-MAPK pathway mutations
Thomas F. Eleveld et al.
NATURE GENETICS (2015)
FAM150A and FAM150B are activating ligands for anaplastic lymphoma kinase
Jikui Guan et al.
ELIFE (2015)
Comparison of RNA-seq and microarray-based models for clinical endpoint prediction
Wenqian Zhang et al.
GENOME BIOLOGY (2015)
Emergence of New ALK Mutations at Relapse of Neuroblastoma
Gudrun Schleiermacher et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
The concordance between RNA-seq and microarray data depends on chemical treatment and transcript abundance
Charles Wang et al.
NATURE BIOTECHNOLOGY (2014)
Sailfish enables alignment-free isoform quantification from RNA-seq reads using lightweight algorithms
Rob Patro et al.
NATURE BIOTECHNOLOGY (2014)
The kinase ALK stimulates the kinase ERK5 to promote the expression of the oncogene MYCN in neuroblastoma
Ganesh Umapathy et al.
SCIENCE SIGNALING (2014)
RET revisited: expanding the oncogenic portfolio
Lois M. Mulligan
NATURE REVIEWS CANCER (2014)
PI3K and MEK inhibitor combinations: examining the evidence in selected tumor types
Carolyn D. Britten
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2013)
Pea3 Transcription Factor Family Members Etv4 and Etv5 Mediate Retrograde Signaling and Axonal Growth of DRG Sensory Neurons in Response to NGF
Paula Fontanet et al.
JOURNAL OF NEUROSCIENCE (2013)
Mechanistic insight into ALK receptor tyrosine kinase in human cancer biology
Bengt Hallberg et al.
NATURE REVIEWS CANCER (2013)
Exon-level expression analyses identify MYCN and NTRK1 as major determinants of alternative exon usage and robustly predict primary neuroblastoma outcome
A. Schramm et al.
BRITISH JOURNAL OF CANCER (2012)
The ALKF1174L Mutation Potentiates the Oncogenic Activity of MYCN in Neuroblastoma
Teeara Berry et al.
CANCER CELL (2012)
Activated ALK Collaborates with MYCN in Neuroblastoma Pathogenesis
Shizhen Zhu et al.
CANCER CELL (2012)
Targeted Expression of Mutated ALK Induces Neuroblastoma in Transgenic Mice
Lukas C. Heukamp et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Activating ALK mutations found in neuroblastoma are inhibited by Crizotinib and NVP-TAE684
Christina Schonherr et al.
BIOCHEMICAL JOURNAL (2011)
miRNA Expression Profiling Enables Risk Stratification in Archived and Fresh Neuroblastoma Tumor Samples
Katleen De Preter et al.
CLINICAL CANCER RESEARCH (2011)
Oncogenic ETS proteins mimic activated RAS/MAPK signaling in prostate cells
Peter C. Hollenhorst et al.
GENES & DEVELOPMENT (2011)
Emerging importance of ALK in neuroblastoma
Anna M. Azarova et al.
SEMINARS IN CANCER BIOLOGY (2011)
A gene expression signature of RAS pathway dependence predicts response to PI3K and RAS pathway inhibitors and expands the population of RAS pathway activated tumors
Andrey Loboda et al.
BMC MEDICAL GENOMICS (2010)
Meta-analysis of Neuroblastomas Reveals a Skewed ALK Mutation Spectrum in Tumors with MYCN Amplification
Sara De Brouwer et al.
CLINICAL CANCER RESEARCH (2010)
Overlapping functions of Pea3 ETS transcription factors in FGF signaling during zebrafish development
Wade A. Znosko et al.
DEVELOPMENTAL BIOLOGY (2010)
Modeling and quantification of cancer cell invasion through collagen type I matrices
Olivier De Wever et al.
INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY (2010)
Medical Progress: Recent Advances in Neuroblastoma.
John M. Maris
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Differentiation in Neuroblastoma: Diffusion-Limited Hypoxia Induces Neuro-Endocrine Secretory Protein 55 and Other Markers of a Chromaffin Phenotype
Fredrik Hedborg et al.
PLOS ONE (2010)
Anaplastic lymphoma kinase: signalling in development and disease
Ruth H. Palmer et al.
BIOCHEMICAL JOURNAL (2009)
Meta-mining of Neuroblastoma and Neuroblast Gene Expression Profiles Reveals Candidate Therapeutic Compounds
Katleen De Preter et al.
CLINICAL CANCER RESEARCH (2009)
RTPrimerDB: the portal for real-time PCR primers and probes
Steve Lefever et al.
NUCLEIC ACIDS RESEARCH (2009)
Pleiotropic Biological Activities of Alternatively Spliced TMPRSS2/ERG Fusion Gene Transcripts
Jianghua Wang et al.
CANCER RESEARCH (2008)
Characterization of TMPRSS2 : ETV5 and SLC45A3 : ETV5 gene fusions in prostate cancer
Beth E. Helgeson et al.
CANCER RESEARCH (2008)
Reduced tumorigenesis in mouse mammary cancer cells following inhibition of Pea3-or Erm-dependent transcription
Virginie Firlej et al.
JOURNAL OF CELL SCIENCE (2008)
Identification of ALK as a major familial neuroblastoma predisposition gene
Yael P. Mosse et al.
NATURE (2008)
High Myc pathway activity and low stage of neuronal differentiation associate with poor outcome in neuroblastoma
Erik Fredlund et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
ERM/ETV5 up-regulation plays a role during myometrial infiltration through matrix metalloproteinase-2 in endometrial cancer
Marta Monge et al.
CANCER RESEARCH (2007)
Identification of NVP-TAE684, a potent, selective, and efficacious inhibitor of NPM-ALK
Anna V. Galkin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
qBase relative quantification framework and software for management and automated analysis of real-time quantitative PCR data
Jan Hellemans et al.
GENOME BIOLOGY (2007)
Ba/F3 cells and their use in kinase drug discovery
Markus Warmuth et al.
CURRENT OPINION IN ONCOLOGY (2007)
Inhibition of phosphatidylinositol 3-kinase destabilizes Mycn protein and blocks malignant progression in neuroblastoma
Louis Chesler et al.
CANCER RESEARCH (2006)
Differential sensitivity of chemoresistant neuroblastoma subtypes to MAPK-targeted treatment correlates with ERK, p53 expression, and signaling response to U0126
AC Eppstein et al.
JOURNAL OF PEDIATRIC SURGERY (2006)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
A developmental switch in the response of DRG neurons to ETS transcription factor signaling
S Hippenmeyer et al.
PLOS BIOLOGY (2005)
The role of the Ets domain transcription factor erm in modulating differentiation of neural crest stem cells
C Paratore et al.
DEVELOPMENTAL BIOLOGY (2002)
分享论文
